Article
Examination of ferrochelatase mutations that cause erythropoietic protoporphyria.
Blood - 15 May 1998
Sellers V M, Dailey T A, Dailey H A
Abstract excerpt
Ferrochelatase (E.C. 4.99.1.1), the enzyme that catalyzes the terminal step in the heme biosynthetic pathway, is the site of defect in the human inherited disease erythropoietic protoporphyria (EPP). Previously it has been demonstrated that patients with EPP may have missense mutations leading to amino acid substitutions, early chain termination, or exon deletions. While it has been clearly demonstrated that two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
